Development and characterization of a 1-2 MeV electron beam platform with magnetic focusing and steering for shallow high-dose-rate irradiation.

Huang J, Hu S, Mo C, Ye Y, Zhang T, Dai Z, Huang Y, Chen Y, Zheng J, Wang J, Bi Y.Phys Med Biol. 2026 Jun 30;71(13). doi: 10.1088/1361-6560/ae7cd3.PMID: 42285143

Class I HDAC inhibition enhances the stem-like memory properties of CRISPR-engineered CAR T cells in neuroblastoma.

Cappabianca D, Toulany M, Zima S, Shea A, Vidugiriene J, Lauer A, Sylvester K, Gnanasekar V, Foster S, Turaga R, Saha K, Ayuso J, Sodji QH.Mol Ther Oncol. 2026 Apr 7;34(2):201200. doi: 10.1016/j.omton.2026.201200. eCollection 2026 Jun 18.PMID: 42058597 Free PMC article.

Integrated Single-Cell and Spatial Analysis Reveals Context-Dependent Myeloid-T Cell Interactions in Response to Immune Checkpoint Blockade in Head and Neck Cancer.

Golfinos-Owens AE, Lozar T, Khatri P, Johns ED, Hu R, Harari PM, Lambert PF, Fitzpatrick MB, Dinh HQ.Clin Cancer Res. 2026 Jun 15;32(12):2494-2507. doi: 10.1158/1078-0432.CCR-25-2300.PMID: 41837744 Free PMC article.

The ESCRT-0 protein HRS regulates hepatocellular lipid droplet catabolism.

Willoughby MM, Shroff A, Crossman BE, Schott MB.Mol Biol Cell. 2026 Jun 11:mbcE25110536. doi: 10.1091/mbc.E25-11-0536. Online ahead of print.PMID: 42275204

Multimodal Artificial Intelligence Prediction of Abiraterone Efficacy in Two STAMPEDE Phase 3 Trials of Non-Metastatic Very High-Risk Prostate Cancer.

Parker CTA, Huang HC, Grist E, Mendes L, Yamashita R, Croucher D, Sachdeva A, Murphy L, Liu VYT, Vidal SS, Todorovic T, Lall S, Goncalves M, Thakali S, Wingate A, Zakka L, Wetterskog D, Nowakowska K, Amos CL; STAMPEDE Collaborators; Berney DM, Tran PT, Spratt DE, Sydes MR, Brown LC, Zhao SG, Nguyen P, Clarke NW, Sweeney CJ, Stewart EL, Parmar MKB, Esteva A, James ND, Attard G.Ann Oncol. 2026 Jun 5:S0923-7534(26)00914-2. doi: 10.1016/j.annonc.2026.05.708. Online ahead of print.PMID: 42250604 Free article.

Identifying and Addressing Barriers to Live Primary Prostate Cancer Cell Research in Veterans.

Carlson A, Heninger E, Recchia EE, Pollen J, Piccolo J, Callahan SC, Zhao SG, Kosoff D.Cancer Res Commun. 2026 Jun 1;6(6):1522-1530. doi: 10.1158/2767-9764.CRC-25-0776.PMID: 42268808 Free PMC article.

Integrating biomarker-derived individual treatment response assessment into Bayesian trial design for personalized cancer treatment.

Kolias P, Ajdari A, Cicchetti A, Jeraj R, Toma-Dasu I, Thorwarth D, Gani C, Thieke C, Nicolay NH, Fiorino C, Bortfeld T, Niyazi M.Radiother Oncol. 2026 Jun;219:111484. doi: 10.1016/j.radonc.2026.111484. Epub 2026 Mar 12.PMID: 41831619 Free article.

Enhanced Antitumor Efficacy of ²²⁵Ac-NM600 Compared to ¹⁷⁷Lu-NM600 in Prostate Cancer Models.

Ferreira CA, Potluri HK, Tantawy AA, Massey CF, Grudzinski JJ, Carston AM, Clemons NB, Idrissou MB, Thickens AS, Rosenkrans ZT, Choi C, Kerr CP, Pinchuk AN, Kwon O, Jeffery JJ, Bednarz BP, Morris ZS, Weichert JP, McNeel DG, Hernandez R.Int J Radiat Oncol Biol Phys. 2026 Jun 1;125(2):566-575. doi: 10.1016/j.ijrobp.2025.09.072. Epub 2025 Nov 29.PMID: 41319721 Free PMC article.

Interactions of Antibody Drug Conjugate Anti-Tubulin and Topoisomerase I Inhibitor Payloads with Radiotherapy to Potentiate Immunotherapy.

Lesperance J, Yung BS, Allevato MM, Cheng MM, Camargo MF, Saddawi-Konefka R, Dhawan K, Sharma AK, Mortaja M, Bice S, Scanderbeg DJ, Alvarado D, Mayadev J, Eskander RN, Adams SR, Cosper PF, Gutkind JS, Advani SJ.Adv Sci (Weinh). 2026 Jun;13(35):e06552. doi: 10.1002/advs.202506552. Epub 2025 Oct 24.PMID: 41133986 Free PMC article.